This is a Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK3773274 in Adults with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Cytokinetics, Inc.
Start Date
May 22, 2020
End Date
March 31, 2023
Administered By
Institutes and Centers
Awarded By
Cytokinetics, Inc.
Start Date
May 22, 2020
End Date
March 31, 2023